{"organizations": [], "uuid": "515852ddc9ea5e4129d328a1ddef90762c86ea55", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/30/pr-newswire-solid-biosciences-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-investors-with-losses-in.html", "country": "US", "domain_rank": 767, "title": "SOLID BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-31T06:50:00.000+03:00", "replies_count": 0, "uuid": "515852ddc9ea5e4129d328a1ddef90762c86ea55"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/30/pr-newswire-solid-biosciences-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-reminds-investors-with-losses-in.html", "ord_in_thread": 0, "title": "SOLID BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Solid Biosciences Inc. - SLDB", "locations": [], "entities": {"persons": [{"name": "charles c. foti", "sentiment": "none"}, {"name": "jr.", "sentiment": "none"}, {"name": "lewis kahn", "sentiment": "none"}], "locations": [{"name": "new orleans", "sentiment": "none"}, {"name": "louisiana", "sentiment": "none"}, {"name": "united states district court", "sentiment": "none"}, {"name": "massachusetts", "sentiment": "none"}, {"name": "louisiana", "sentiment": "none"}], "organizations": [{"name": "kahn swick & foti", "sentiment": "neutral"}, {"name": "lead plaintiff deadline in class action lawsuit against solid biosciences inc.", "sentiment": "neutral"}, {"name": "solid biosciences inc.", "sentiment": "none"}, {"name": "solid biosciences", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW ORLEANS, March 30, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC (\"KSF\") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 28, 2018 to file lead plaintiff applications in a lawsuit against Solid Biosciences Inc. (NasdaqGS: SLDB), if they purchased the Company's shares between January 25, 2018, and March 14, 2018 (the \"Class Period\") or in its January 25, 2018 initial public offering (\"IPO\"). This action is pending in the United States District of Massachusetts.\nWhat You May Do\nIf you purchased shares of Solid Biosciences and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ( lewis.kahn@ksfcounsel.com ), or visit https://www.ksfcounsel.com/cases/nasdaqgs-sldb/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 28, 2018 .\nAbout the Lawsuit\nSolid Biosciences and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.\nOn January 30, 2018, a report co-authored by a former scientific advisor of the Company revealed risks of high systemic dosing using the Company's delivery system, AAV or adeno-associated virus, for its lead drug candidate SGT-001. Then, on March 14, 2018, the Company disclosed a clinical hold placed on the SGT-001 trial by the FDA relating to adverse events.\nOn this news, the price of Solid Biosciences' shares plummeted over 60% to $9.32/share on March 15, 2018.\nAbout Kahn Swick & Foti, LLC\nKSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.\nTo learn more about KSF, you may visit www.ksfcounsel.com .\nContact:\nKahn Swick & Foti, LLC\nLewis Kahn, Managing Partner\nlewis.kahn@ksfcounsel.com\n1-877-515-1850\n206 Covington St.\nMadisonville, LA 70447\nView original content with multimedia: http://www.prnewswire.com/news-releases/solid-biosciences-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick--foti-llc-reminds-investors-with-losses-in-excess-of-1 -of-lead-plaintiff-deadline-in-class-action-lawsuit-against-solid-biosciences-inc-300622257.html\nSOURCE Kahn Swick & Foti, LLC", "external_links": ["http://www.prnewswire.com/news-releases/solid-biosciences-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick--foti-llc-reminds-investors-with-losses-in-excess-of-100000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-solid-biosciences-inc-300622257.html", "https://www.ksfcounsel.com/cases/nasdaqgs-sldb/", "http://www.ksfcounsel.com/"], "published": "2018-03-31T06:50:00.000+03:00", "crawled": "2018-03-31T06:50:51.006+03:00", "highlightTitle": ""}